Dihydrotestosterone
DHT
Description
"Dihydrotestosterone" (DHT) test evaluates the amount of DHT, a potent form of testosterone, circulating in your blood. Elevated levels can contribute to issues like hair loss, oily skin, acne, or prostate enlargement. Doctors often recommend this test when symptoms like thinning hair or urinary difficulties arise. A blood sample provides insight into hormonal balance. Based on results, care plans may involve medications, lifestyle adjustments, or further hormone testing. Monitoring DHT supports better management of skin, hair, and prostate health.
Category
Hormones
Procedure
Invasive
Sample Type
Blood – Serum
Units
Nanograms Per Deciliter
Procedure Category
Blood Draw
Test Group
Hormone Health Group, Complete Sex Hormone Group
Test Group Description
Complete Sex Hormone Group: This comprehensive panel offers an extensive evaluation of sex hormone status and reproductive health, providing detailed insights into hormonal balance and function. Hormone Health Group: Its focus is on evaluating hormone levels and function, providing insights into hormonal balance and associated health conditions.
Optimal Range
For Men:
Conventional Unit: 50.00–65.00 ng/dL
SI Unit: 1.72–2.24 nmol/L
For Women:
Conventional Unit: 3.00–15.00 ng/dL
SI Unit: 0.10–0.52 nmol/L
Normal Range
For Men:
Conventional Unit: 30.00–85.00 ng/dL
SI Unit: 1.04–2.94 nmol/L
For Women:
Conventional Unit: 4.00–22.00 ng/dL
SI Unit: 0.14–0.76 nmol/L
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
5-alpha-reductase overactivity (Increased activity of the enzyme 5-alpha-reductase)
Androgenic alopecia (Male pattern baldness)
Benign prostatic hyperplasia (Enlargement of the prostate gland)
Congenital adrenal hyperplasia (Genetic disorder affecting adrenal gland function)
Hormone replacement therapy
- ...
Key Reasons For Testing
Androgen Assessment: Evaluates DHT’s role in androgen metabolism and hormonal balance.
Male Development: Provides insights into reproductive health and male sexual development during puberty and fetal growth.
Hair Loss: Assesses DHT’s role in male pattern baldness, aiding in hair restoration strategies.
Prostate Health: Evaluates risks for conditions like BPH and prostate cancer linked to elevated DHT levels.
Androgenic Effects: Examines DHT’s impact on muscle growth, libido, and skin health.
Acne Risk: Identifies hormonal contributions to acne, especially in adolescents.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med. 2004;350(22):2239-2246.
[2] Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab.2005;90(3):1502-1510.
[3] Clark RV, Hermann DJ, Cunningham GR, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184.
[4] Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev. 1993;14(5):577-593.
[5] Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 1992;327(17):1185-1191.
[6] Griffin JE, Wilson JD. The androgen resistance syndromes: 5 alpha-reductase deficiency, testicular feminization, and related disorders. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 5th ed. Philadelphia, PA: Elsevier Saunders; 2006:1471-1486.
[7] Habib FK, Ross M, Ho CK, et al. Androgen receptor status and response to antiandrogens in human prostate carcinoma. J Clin Endocrinol Metab. 2000;85(10):3462-3470.
[8] Anderson KM, Liao S. Selective retention of dihydrotestosterone by prostatic nuclei. Nature. 1968;219(5156):277-279.
[9] Frye CA. Effects and mechanisms of testosterone and its metabolites in the central nervous system. Front Neuroendocrinol. 2001;22(3):251-269.
[10] Andriole GL, Bostwick D, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med.2010;362(13):1192-1202.
[11] Huggins C, Hodges CV. Studies on prostatic cancer. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1(4):293-297.
[12] Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5-alpha-reductase deficiency. N Engl J Med. 1979;300(22):1233-1237.
[13] Bieber EJ, Bieber JD. Androgen excess: Molecular and clinical overview. Endocrinol Metab Clin North Am.1992;21(2):383-393.
[14] Makridakis NM, Ross RK, Pike MC, Henderson BE, Reichardt JK. Association of mis-sense mutation in the SRD5A2 gene with prostate cancer in African-American and Hispanic men. J Urol. 1999;161(5):1436-1439.
[15] Schreiber SN, Knobloch J, Eisenegger C, et al. The role of dihydrotestosterone in neurobehavioral functions and its interaction with serotonin. Neuroendocrinology. 2015;101(3):216-228.